Evaluation of HER2/neu Expression in High-Grade Endometrial Carcinoma and Its Clinicopathological Correlation
Background & Objective: Endometrial carcinoma (EC) has been traditionally classified into two distinct categories of low-grade and high-grade. Type I (low grade) EC, which constitutes the majority of cases, is linked to estrogen-related molecular pathways. But type II (high-grade) EC accounts fo...
Saved in:
Main Authors: | Soheila Sarmadi (Author), Narges Izadi-Mood (Author), Nazanin Mansourzadeh (Author), Dorna Motevalli (Author) |
---|---|
Format: | Book |
Published: |
Iranian Society of Pathology,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Napsin-A Expression, a Reliable Immunohistochemical Marker for Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas
by: Fatemeh Nili, et al.
Published: (2020) -
Expression of HER2/neu in gastric adenocarcinoma and its correlation with serum HER2/neu level and E-cadherin expression
by: Ishan Pandey, et al.
Published: (2022) -
Correlation of histological grade with Estrogen, Progesterone and HER2/neu reactivity in breast cancer
by: Girishma Shrestha, et al.
Published: (2019) -
Altered PTEN expression; a diagnostic marker for differentiating normal, hyperplastic and neoplastic endometrium
by: Sotoudeh Kambiz, et al.
Published: (2009) -
Expression of Her-2/neu in extrahepatic cholangiocarcinoma
by: Shamekh R, et al.
Published: (2017)